SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-003160
Filing Date
2017-11-28
Accepted
2017-11-28 16:34:58
Documents
4
Period of Report
2017-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K peregrine_8k.htm 8-K 33481
2 SETTLEMENT AGREEMENT peregrine_ex1001.htm EX-10.1 160621
3 PRESS RELEASE peregrine_ex9901.htm EX-99.1 18734
4 GRAPHIC image_001.jpg GRAPHIC 3834
  Complete submission text file 0001683168-17-003160.txt   219753
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 171225813
SIC: 2834 Pharmaceutical Preparations